Baxter
BAX
#1140
Rank
โ‚ฌ15.49 B
Marketcap
30,35ย โ‚ฌ
Share price
0.82%
Change (1 day)
-7.07%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

EPS for Baxter (BAX)

EPS in 2023 (TTM): 4,84ย โ‚ฌ

According to Baxter's latest financial reports the company's current EPS (TTM) is 4,86ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -4,59ย โ‚ฌ a decrease over its 2021 EPS that were of 2,43ย โ‚ฌ.

EPS history for Baxter from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)4,84ย โ‚ฌ-205.44%
2022-4,59ย โ‚ฌ-288.67%
20212,43ย โ‚ฌ18.52%
20202,05ย โ‚ฌ10.2%
20191,86ย โ‚ฌ-34.45%
20182,84ย โ‚ฌ126.52%
20171,25ย โ‚ฌ-85.45%
20168,61ย โ‚ฌ411.9%
20151,68ย โ‚ฌ-61.48%
20144,37ย โ‚ฌ24.32%
20133,51ย โ‚ฌ-12.32%
20124,01ย โ‚ฌ7.93%
20113,71ย โ‚ฌ61.57%
20102,30ย โ‚ฌ-33.52%
20093,46ย โ‚ฌ12.69%
20083,07ย โ‚ฌ21.89%
20072,52ย โ‚ฌ23.26%
20062,04ย โ‚ฌ38.71%
20051,47ย โ‚ฌ146.03%
20040,60ย โ‚ฌ-58%
20031,42ย โ‚ฌ17.8%
20021,21ย โ‚ฌ12.19%
20011,08ย โ‚ฌ-11.67%
20001,22ย โ‚ฌ5.32%
19991,16ย โ‚ฌ141.23%
19980,48ย โ‚ฌ7.55%
19970,45ย โ‚ฌ-42.55%
19960,78ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
0,96ย โ‚ฌ-80.27%๐Ÿ‡บ๐Ÿ‡ธ USA
6,47ย โ‚ฌ 33.01%๐Ÿ‡บ๐Ÿ‡ธ USA
0,78ย โ‚ฌ-83.98%๐Ÿ‡บ๐Ÿ‡ธ USA
5,27ย โ‚ฌ 8.40%๐Ÿ‡บ๐Ÿ‡ธ USA
1,65ย โ‚ฌ-66.02%๐Ÿ‡บ๐Ÿ‡ธ USA
14,57ย โ‚ฌ 199.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,23ย โ‚ฌ-125.20%๐Ÿ‡บ๐Ÿ‡ธ USA
2,58ย โ‚ฌ-46.88%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-1,92ย โ‚ฌ-139.45%๐Ÿ‡บ๐Ÿ‡ธ USA